No abstract available
MeSH terms
-
COVID-19*
-
Child
-
Humans
-
Immunologic Factors
-
Immunosuppressive Agents
-
Nephrotic Syndrome* / drug therapy
-
Pandemics
-
Recurrence
-
Remission Induction
-
Rituximab / therapeutic use
-
Treatment Outcome
Substances
-
Immunologic Factors
-
Immunosuppressive Agents
-
Rituximab